VIS832, a novel CD138-targeting monoclonal antibody, potently induces killing of human multiple myeloma and further synergizes with IMiDs or bortezomib in vitro and in vivo - Concepedia

Concepedia

Publication | Open Access

VIS832, a novel CD138-targeting monoclonal antibody, potently induces killing of human multiple myeloma and further synergizes with IMiDs or bortezomib in vitro and in vivo

DOI Full Paper Access

42

Citations

39

References

2020

Year

Tengteng Yu, Bharat K. R. Chaganty, Liang Lin, Lijie Xing, Boopathy Ramakrishnan, Kenneth Wen, Phillip A. Hsieh, Andrew M. Wollacott, Karthik Viswanathan, Hedy Adari,

Blood Cancer Journal

References

	Year	Citations

Page 1